Biotechnology GrowGeneration Reports Q4 & 2023 Results: Sales Dip, Earns More Per Sale Thanks To Smart Product Strategy – GrowGeneration (NASDAQ:GRWG) Read more
Biotechnology Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers – AnaptysBio (NASDAQ:ANAB) Read more